QIP on baseline prolactin monitoring in psychiatric inpatients on antipsychotics. Issue 5 (September 2015)

• Record Type: Journal Article
• Authors: Ali, Shaazneen; Thomas, Emily Simon; Looby, Saran; Beveridge, Ed
• Is Part Of: Progress in neurology and psychiatry. Volume 19:Issue 5(2015)
• Page Start: 21
• Page End: 24
• Publication Date: 2015-09
• Subjects: Neurology -- Periodicals; Psychiatry -- Periodicals; Nervous system -- Periodicals; 616.805
• DOI: 10.1002/pnp.397
• Languages: English
• ISSNs: 1367-7543

Abstract

<abstract abstract-type="main" id="pnp397-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Mental health patients suffer higher rates of mortality and morbidity due to physical health problems. A number of antipsychotics are associated with significant increases in plasma prolactin levels and the risk of hyperprolactinaemia. The importance of physical health monitoring is increasingly recognised and commissioned for in mental health services. In the context of greater focus on physical health monitoring in mental health settings, this project set out to assess and improve compliance with guidance on baseline prolactin level testing of inpatients on antipsychotics.</p> </abstract>